Bharathnag Nagappa

Bharathnag Nagappa

Auto-generated profile, based on publicly available information

Bharathnag Nagappa

Department of Community Medicine, Sri Siddhartha Medical College and Hospital, Tumakuru, Karnataka 572107, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Indian Journal of Tuberculosis
Verified
Journal Article
Closed access
YMYamini Marimuthu
Yamini Marimuthu
BNBharathnag Nagappa
Bharathnag Nagappa
NSNandini Sharma
Nandini Sharma
SBSaurav Basu
Saurav Basu
KCKamal Kishore Chopra
Kamal Kishore Chopra

30 May 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
BNBharathnag Nagappa
Bharathnag Nagappa
YMYamini Marimuthu
Yamini Marimuthu
Bharathnag Nagappa, Yamini Marimuthu; Seroconversion rate and diagnostic accuracy of serological tests for COVID-19, Clinical Infectious Diseases, , ciaa676, h

15 June 2023 in Indian Journal of Tuberculosis
Verified
Journal Article
Closed access
YMYamini Marimuthu
Yamini Marimuthu
GNGreshma Chandrasekharan Nair
Greshma Chandrasekharan Nair
UNUmesh Nagesh
Umesh Nagesh
AAAmal Anand
Amal Anand
KCKamal Kishore Chopra
Kamal Kishore Chopra
NNNeha Nagaraj
Neha Nagaraj

12 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DBDebajyoti Bhattacharyya
Debajyoti Bhattacharyya
NRNeeraj Raizada
Neeraj Raizada
BNBharathnag Nagappa
Bharathnag Nagappa
ATArvind Tomar
Arvind Tomar
PMPrateek Maurya
Prateek Maurya
NSNikky Singh
Nikky Singh
Background: There are apprehensions amongst healthcare worker (HCWs) about COVID-19. The HCWs have been given hydroxychloroquine (HCQ) chemoprophylaxis for seven weeks as per Government of India guidelines. Objectives: To assess the apprehensions amongst HCWs about COVID-19 and to document accessibility, adherence and side effects related to HCQ prophylaxis in HCWs. Methods: A longitudinal follow up study was conducted in a tertiary care hospital. HCQ was given in the dose of 400 mg twice on day one, and then 400 mg weekly for seven weeks. 391 HCWs were interviewed using semi structured questionnaire. Results: 62.2% HCWs expressed perceived danger posted by COVID-19 infection. Doctors (54%) showed least acceptance and paramedics (88%) showed highest acceptance to chemoprophylaxis. 17.5% participants developed at least one of the side effects to HCQ. Females and nursing profession were significantly associated with adverse effects. Common side effects were gastro-intestinal symptoms, headache and abnormal mood change. Most of these were mild, not requiring any intervention. Gender, professions and perceived threat of COVID-19 were significantly associated with acceptance and adherence to HCQ prophylaxis. Conclusion: Two third of HCWs had perceived danger due to COVID-19. Three fourth of the HCWs accepted chemoprophylaxis and four out of five who accepted had complete adherence to prophylaxis schedule. One out of five had developed at least one of side effects; however, most of these were mild not requiring any intervention.

14 August 2021 in Indian Journal of Tuberculosis
Verified
Journal Article
Closed access
YMYamini Marimuthu
Yamini Marimuthu
RKRadhika Kunnavil
Radhika Kunnavil
NSN. Satyanarayana
N. Satyanarayana
NAN.S. Anil
N.S. Anil
JKJeetendra Kumar
Jeetendra Kumar
BNBharathnag Nagappa
Bharathnag Nagappa

6 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
BNBharathnag Nagappa
Bharathnag Nagappa
MSManikandanesan Sakthivel
Manikandanesan Sakthivel
YMYamini Marimuthu
Yamini Marimuthu
ARAayushi Rastogi
Aayushi Rastogi
ARArchana Ramalingam
Archana Ramalingam
SSShiv Kumar Sarin
Shiv Kumar Sarin
Objectives: The study aimed to estimate the disease burden due to COVID-19 in the scenarios of unchecked spread and with various public health interventions in New Delhi. Methods: We adopted Susceptible, Exposed, Infected and Recovered (SEIR) model to estimate the course of COVID-19 outbreak in Delhi population and effect of public health intervention on the pandemic. We first estimated the basic reproductive rate (R 0 ) based on the evidence from Wuhan, then ran the model considering no intervention implemented, followed by case isolation, social distancing, and lockdown, each implemented in isolation and in combinations to estimate the number of cases. Markov’s model was used to estimate the number of cases in various clinical scenarios of the disease. Sensitivity analysis conducted to estimate the effect of asymptomatic cases on case based interventions. Results: Estimated R 0 in Delhi population was 6.18 (range 4.15 – 12.2). Effective reproductive rate (R t ) was least for case isolation (3.5). Lockdown showed highest reduction (28%) in number of prevalent cases on peak day and 22% reduction in patients in need of intensive care unit (ICU). Case isolation and lockdown together resulted in 50% reduction in number of prevalent cases and 42% reduction in patients in need of ICU care. Sensitivity analysis showed that the effect of case isolation was inversely proportionate to the proportion of asymptomatic (hidden) cases. Conclusions: Interventions should be implemented in combinations of individual and community level interventions to gain better outcome. Identifying and isolation of all cases as early as possible is important to flatten the pandemic curve.